COMMUNIQUÉS West-GlobeNewswire
-
Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
03/02/2026 -
Berry Street Named to 2026 New York Digital Health 100 List
03/02/2026 -
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
03/02/2026 -
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE®, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3
03/02/2026 -
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program
03/02/2026 -
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
03/02/2026 -
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
03/02/2026 -
MedRisk Acquires Horizon Casualty Services
03/02/2026 -
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
03/02/2026 -
Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Appointed to the Florida Board of Pharmacy by Governor Ron DeSantis
03/02/2026 -
Clever Care Health Plan Increases Enrollment by Nearly 50 Percent in 2026 Medicare Annual Enrollment Period
03/02/2026 -
Eleusis to Debut as the World’s First Legal Luxury Psychedelic Immersion
03/02/2026 -
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026
03/02/2026 -
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
03/02/2026 -
Adam Ferrari Announces 2026 Health Science Scholarship to Support Students Dedicated to Caring for Patients with Physical Disabilities
03/02/2026 -
Cynet Named a Strong Performer in 2026 Gartner Peer Insights™ “Voice of the Customer” for Endpoint Protection Platforms
03/02/2026 -
AdhereHealth Announces Appointment of CEO Kempton Presley and President & COO Patrick McNulty as Members of the Board of Directors
03/02/2026 -
Department of Education Proposal Still Excludes Nursing from “Professional Degree” Definition
03/02/2026 -
SRx Health Solutions Significantly Reduces Short Position of Cryptocurrency Portfolio Amidst Current Market Volatility
03/02/2026
Pages